Profiling of actionable gene alterations in ovarian cancer by targeted deep sequencing

Author：

E-ISSN： 1791-2423|46|6|2389-2398

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.46, Iss.6, 2015-01, pp. : 2389-2398

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ovarian cancer stem cell-specific gene expression profiling and targeted drug prescreening

Oncology Reports, Vol. 31, Iss. 3, 2014-01 ,pp. : 1235-1248

Spandidos Publications

Access to resources Recommend Favorite

Targeted Gene Therapy of Ovarian Cancer Using an Ovarian-Specific Promoter

By Bao R. Selvakumaran M. Hamilton T.C.

Gynecologic Oncology, Vol. 84, Iss. 2, 2002-02 ,pp. : 228-234

Elsevier

Access to resources Recommend Favorite

Deep Sequencing in Cancer Research

By Yoshida Kenichi Sanada Masashi Ogawa Seishi

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 2, 2013-02 ,pp. : 110-115

Oxford University Press

Access to resources Recommend Favorite

Identification and characterization of missense alterations in the BRCA1 associated RING domain (BARD1) gene in breast and ovarian cancer

By Vogiatzi Paraskevi

The Women's Oncology Review, Vol. 5, Iss. 4, 2005-12 ,pp. : 213-216

Informa Healthcare

Access to resources Recommend Favorite

Alterations in SPARC and VEGF Immunoreactivity in Epithelial Ovarian Cancer

By Paley P.J. Goff B.A. Gown A.M. Greer B.E. Sage E.H.

Gynecologic Oncology, Vol. 78, Iss. 3, 2000-09 ,pp. : 336-341

Elsevier

Access to resources Recommend Favorite